West Pharmaceutical Services, Inc.

Equities

WST

US9553061055

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:01 2024-04-26 pm EDT 5-day change 1st Jan Change
360.4 USD -2.10% Intraday chart for West Pharmaceutical Services, Inc. -3.12% +2.36%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating MT
Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423 MT
Health Care Drops Amid Mixed Earnings -- Health Care Roundup DJ
West Pharmaceutical's Q1 Adjusted Earnings, Net Sales Fall; 2024 Adjusted EPS Outlook Raised MT
Transcript : West Pharmaceutical Services, Inc., Q1 2024 Earnings Call, Apr 25, 2024
Stephens Adjusts West Pharmaceutical Services Price Target to $420 From $400 MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Reports Q1 Revenue $695.4M, vs. Street Est of $671.7M MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Posts Q1 EPS $1.56, vs. Street Est of $1.29 MT
West Pharmaceutical Services, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
West Pharmaceutical Services, Inc. Reaffirms Earnings Guidance for the Full Year 2024 CI
West Pharmaceutical Services, Inc. Announces Third Quarter 2024 Dividend, Payable on August 7, 2024 CI
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says RE
Transcript : West Pharmaceutical Services, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-19-2024 09:00 AM
Pacific Edge's Chair to Retire; Shares Fall 3% MT
West Pharmaceutical Services Inc Files a Definitive Proxy Statement CI
Transcript : West Pharmaceutical Services, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 01:05 PM
West Pharmaceutical Services Insider Sold Shares Worth $292,436, According to a Recent SEC Filing MT
Accenture: acquisition of Australian company The Lumery CF
West Pharmaceutical Services Inc Receives a Shareholder Proposal from John Chevedden CI
West Pharmaceutical Services Insider Sold Shares Worth $724,061, According to a Recent SEC Filing MT
West Pharmaceutical Services Insider Sold Shares Worth $2,559,380, According to a Recent SEC Filing MT
West Pharmaceutical Services Maintains Quarterly Dividend at $0.20 per Share; Payable May 1 to Holders of Record on April 24 MT
West Pharmaceutical Services, Inc. Announces Second Quarter 2024 Dividend, Payable on May 1, 2024 CI
UBS Cuts West Pharmaceutical Services Price Target to $375 From $400, Maintains Neutral Rating MT
Deutsche Bank Raises West Pharmaceutical Services Price Target to $355 From $350, Maintains Hold Rating MT
Chart West Pharmaceutical Services, Inc.
More charts
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - own manufactured products (81.8%); - products manufactured under contract (18.2%). Net sales are distributed geographically as follows: the United States (42.3%), Germany (16.8%), Ireland (8.7%), France (7.5%), Europe (12.1%) and other (12.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
368.2 USD
Average target price
391.6 USD
Spread / Average Target
+6.37%
Consensus
  1. Stock Market
  2. Equities
  3. WST Stock
  4. News West Pharmaceutical Services, Inc.
  5. West Pharmaceutical Services : Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Posts Q2 Revenue $723.6M, vs. Street Est of $669.4M